{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:03:52Z","timestamp":1746417832544,"version":"3.40.4"},"reference-count":70,"publisher":"APO Society of Specialists in Heart Failure","issue":"7S","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>The role of nutrition in the development and progression of atherosclerosis is well known. The correction of diet in patients with dyslipidemia is important as an independent intervention (in the group of patients with low and, partially, moderate cardiovascular risk), and as an addition to drug therapy in patients with at higher risk of cardiovascular events. The current review describes the effect of modern methods of diet therapy, as well as the use of a number of nutraceutical agents in terms of evidence-based medicine.<\/jats:p>","DOI":"10.18087\/cardio.2549","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T13:05:06Z","timestamp":1566565506000},"page":"4-14","source":"Crossref","is-referenced-by-count":0,"title":["Non-pharmaceutical treatment of dyslipidemia: review of current methods of diet and nutraceuticals"],"prefix":"10.18087","volume":"59","author":[{"given":"N. V.","family":"Polenova","sequence":"first","affiliation":[{"name":"Federal Research Center of Nutrition and Biotechnology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"Kosura","sequence":"additional","affiliation":[{"name":"Federal Research Center of Nutrition and Biotechnology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu. R.","family":"Varaeva","sequence":"additional","affiliation":[{"name":"Federal Research Center of Nutrition and Biotechnology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. N.","family":"Livancova","sequence":"additional","affiliation":[{"name":"Federal Research Center of Nutrition and Biotechnology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Starodubova","sequence":"additional","affiliation":[{"name":"Federal Research Center of Nutrition and Biotechnology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7442","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H et al. 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal. 2016;37(39):2999\u20133058. DOI: 10.1093\/eurheartj\/ehw272","DOI":"10.1093\/eurheartj\/ehw272"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Josan K, Majumdar SR, McAlister FA. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. Canadian Medical Association Journal. 2008;178(5):576\u201384. DOI: 10.1503\/cmaj.070675","DOI":"10.1503\/cmaj.070675"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. The Lancet. 2005;366(9493):1267\u201378. DOI: 10.1016\/S0140-6736(05)67394-1","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Banach M, Jankowski P, J\u00f3\u017awiak J, Cybulska B, Windak A, Guzik T et al. PoLA\/CFPiP\/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016. Archives of Medical Science. 2017;13(1):1\u201345. DOI: 10.5114\/aoms.2017.64712","DOI":"10.5114\/aoms.2017.64712"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Boytsov S. A., Pogosova N.V., Bubnova M.G., Drapkina O.M., Gavrilova N.E., Yeganyan R.A. et al. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;23 (6):7\u2013122. [Russian: Boitsov S.A., Pogosova N.V., Bubnova M.G., Drapkina O.M., Gavrilova N.E., Eganyan R.A. i dr. Kardiovaskulyarnaya profilaktika 2017. Rossiiskie natsional'nye rekomendatsii. Rossiiskii kardiologicheskii zhurnal. 2018;23(6):7\u2013122]. DOI: 10.15829\/1560-4071-2018-6-7-122","DOI":"10.15829\/1560-4071-2018-6-7-122"},{"key":"ref6","unstructured":"Ezhov M.V., Sergienko I.V., Aronov D.M., Arabidze G.G., Akhmedzhanov N.M., Bazhan S. S. et al. Diagnostics and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis. Russian recommendations VI revision. Atherosclerosis and Dyslipidemias. 2017;3:5\u201322. [Russian: Ezhov M.V., Sergienko I.V., Aronov D.M., Arabidze G.G., Akhmedzhanov N.M., Bazhan S.S. i dr. Diagnostika i korrektsiya narushenii lipidnogo obmena s tsel'yu profilaktiki i lecheniya ateroskleroza. Rossiiskie rekomendatsii, VI peresmotr. Ateroskleroz i dislipidemii. 2017;3:5-22]"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R et al. An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia. Atherosclerosis. 2014;232(2):410\u20133. DOI: 10.1016\/j.atherosclerosis.2013.11.031","DOI":"10.1016\/j.atherosclerosis.2013.11.031"},{"key":"ref8","unstructured":"Baranovsky A.Yu. Dietology. 5th edition. -St. Petersburg: Piter; 1104 p. [Russian: Baranovskii A.Yu. Dietologiya. 5-e izdanie. \u2013 SPb.: Piter, 2018. \u2013 1104s]. ISBN 978-5-496-02276-7"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Musunuru K. Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention. Lipids. 2010;45(10):907\u201314. DOI: 10.1007\/s11745-010-3408-1","DOI":"10.1007\/s11745-010-3408-1"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Wolfram G, Bechthold A, Boeing H, Ellinger S, Hauner H, Kroke A et al. Evidence-Based Guideline of the German Nutrition Society: Fat Intake and Prevention of Selected Nutrition-Related Diseases. Annals of Nutrition and Metabolism. 2015;67(3):141\u2013204. DOI: 10.1159\/000437243","DOI":"10.1159\/000437243"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts). European Journal of Preventive Cardiology. 2016;23(11):NP1\u201396. DOI: 10.1177\/2047487316653709","DOI":"10.1177\/2047487316653709"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. The New England Journal of Medicine. 1997;336(16):1117\u201324. DOI: 10.1056\/NEJM199704173361601","DOI":"10.1056\/NEJM199704173361601"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. The New England Journal of Medicine. 2001;344(1):3\u201310. DOI: 10.1056\/NEJM200101043440101","DOI":"10.1056\/NEJM200101043440101"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER, Lin P-H et al. Effects on blood lipids of a blood pressure\u2013lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. The American Journal of Clinical Nutrition. 2001;74(1):80\u20139. DOI: 10.1093\/ajcn\/74.1.80","DOI":"10.1093\/ajcn\/74.1.80"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Chiu S, Bergeron N, Williams PT, Bray GA, Sutherland B, Krauss RM. Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial1\u20133. The American Journal of Clinical Nutrition. 2016;103(2):341\u20137. DOI: 10.3945\/ajcn.115.123281","DOI":"10.3945\/ajcn.115.123281"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases\u2014Incidence: A systematic review and meta-analysis on observational prospective studies. Nutrition. 2013;29(4):611\u20138. DOI: 10.1016\/j.nut.2012.12.018","DOI":"10.1016\/j.nut.2012.12.018"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Castro-Quezada I, Rom\u00e1n-Vi\u00f1as B, Serra-Majem L. The Mediterranean Diet and Nutritional Adequacy: A Review. Nutrients. 2014;6(1):231\u201348. DOI: 10.3390\/nu6010231","DOI":"10.3390\/nu6010231"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Martinez-Lacoba R, Pardo-Garcia I, Amo-Saus E, EscribanoSotos F. Mediterranean diet and health outcomes: a systematic meta-review. European Journal of Public Health. 2018;28(5):955\u201361. DOI: 10.1093\/eurpub\/cky113","DOI":"10.1093\/eurpub\/cky113"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Carlos S, De La Fuente-Arrillaga C, Bes-Rastrollo M, Razquin C, Rico-Camp\u00e0 A, Mart\u00ednez-Gonz\u00e1lez M et al. Mediterranean Diet and Health Outcomes in the SUN Cohort. Nutrients. 2018;10(4):439. DOI: 10.3390\/nu10040439","DOI":"10.3390\/nu10040439"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Alvarez-Alvarez I, Zazpe I, P\u00e9rez de Rojas J, Bes-Rastrollo M, RuizCanela M, Fernandez-Montero A et al. Mediterranean diet, physical activity and their combined effect on all-cause mortality: The Seguimiento Universidad de Navarra (SUN) cohort. Preventive Medicine. 2018;106:45\u201352. DOI: 10.1016\/j.ypmed.2017.09.021","DOI":"10.1016\/j.ypmed.2017.09.021"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Van Horn L, Carson JAS, Appel LJ, Burke LE, Economos C, Karmally W et al. Recommended Dietary Pattern to Achieve Adherence to the American Heart Association\/American College of Cardiology (AHA\/ACC) Guidelines: A Scientific Statement From the American Heart Association. Circulation. 2016;134(22):e505\u201329. DOI: 10.1161\/CIR.0000000000000462","DOI":"10.1161\/CIR.0000000000000462"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Ros E, Mart\u00ednez-Gonz\u00e1lez MA, Estruch R, Salas-Salvad\u00f3 J, Fit\u00f3 M, Mart\u00ednez JA et al. Mediterranean Diet and Cardiovascular Health: Teachings of the PREDIMED Study. Advances in Nutrition. 2014;5(3):330S-336S. DOI: 10.3945\/an.113.005389","DOI":"10.3945\/an.113.005389"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. The Lancet. 2017;390(10107):2050\u201362. DOI: 10.1016\/S0140-6736(17)32252-3","DOI":"10.1016\/S0140-6736(17)32252-3"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Mente A, Dehghan M, Rangarajan S, McQueen M, Dagenais G, Wielgosz A et al. Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study. The Lancet Diabetes & Endocrinology. 2017;5(10):774\u201387. DOI: 10.1016\/S2213-8587(17)30283-8","DOI":"10.1016\/S2213-8587(17)30283-8"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Najjar RS, Moore CE, Montgomery BD. A defined, plant-based diet utilized in an outpatient cardiovascular clinic effectively treats hypercholesterolemia and hypertension and reduces medications. Clinical Cardiology. 2018;41(3):307\u201313. DOI: 10.1002\/clc.22863","DOI":"10.1002\/clc.22863"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Appleby PN, Key TJ. The long-term health of vegetarians and vegans. Proceedings of the Nutrition Society. 2016;75(3):287\u201393. DOI: 10.1017\/S0029665115004334","DOI":"10.1017\/S0029665115004334"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Jian Z-H, Chiang Y-C, Lung C-C, Ho C-C, Ko P-C, Ndi Nfor O et al. Vegetarian diet and cholesterol and TAG levels by gender. Public Health Nutrition. 2015;18(4):721\u20136. DOI: 10.1017\/S1368980014000883","DOI":"10.1017\/S1368980014000883"},{"key":"ref28","unstructured":"Kostyuk V.A. Plant polyphenolic compounds as components of functional nutrition. Proceedings Of Belarusian State University. 2016;11(1):32\u201341. [Russian: Kostyuk V.A. Rastitel'nye polifenol'nye soedineniya kak komponenty funktsional'nogo pitaniya. Trudy Belorusskogo gosudarstvennogo universiteta. 2016;11(1):32\u201341]"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Denisenko T.A., Vishnikin A.B., Tsiganok L.P. Reaction features of 18-molibdodiphosphate and folin-ciocalteu reagent with phenolic compounds. Analytics and control. 2015;19(3):242\u201351. [Russian: Denisenko T.A., Vishnikin A.B., Tsyganok L.P. Osobennosti vzaimodeistviya 18-molibdodifosfata i reaktiva Folina-Chokal'teu s fenol'nymi soedineniyami. Analitika i kontrol'. 2015;19(3):242-51]","DOI":"10.15826\/analitika.2015.19.3.001"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Magrone T, Russo MA, Jirillo E. Cocoa and Dark Chocolate Polyphenols: From Biology to Clinical Applications. Frontiers in Immunology. 2017;8:677. DOI: 10.3389\/fimmu.2017.00677","DOI":"10.3389\/fimmu.2017.00677"},{"key":"ref31","unstructured":"Watson RR, Preedy VR, Zibadi S. Polyphenols. mechanisms of action in human health and disease Volume 1 Volume 1. Elsevier; 470 p. ISBN 978-0-12-813007-0"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Rossi RE, Whyand T, Caplin ME. Benefits of Xanthohumol in Hyperlipidaemia, Obesity and Type 2 Diabetes Mellitus: A Review. Journal of Obesity and Chronic Diseases. 2019;3(1):14\u20138. DOI: 10.17756\/jocd.2019-023","DOI":"10.17756\/jocd.2019-023"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Cicero AFG, Colletti A, Bajraktari G, Descamps O, Djuric DM, Ezhov M et al. Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Archives of Medical Science. 2017;13(5):965\u20131005. DOI: 10.5114\/aoms.2017.69326","DOI":"10.5114\/aoms.2017.69326"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Houston M. The Role of Nutraceutical Supplements in the Treatment of Dyslipidemia: Dyslipidemia and Nutrititional Supplements. The Journal of Clinical Hypertension. 2012;14(2):121\u201332. DOI: 10.1111\/j.1751-7176.2011.00576.x","DOI":"10.1111\/j.1751-7176.2011.00576.x"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Ferguson JJA, Stojanovski E, MacDonald-Wicks L, Garg ML. Fat type in phytosterol products influence their cholesterol-lowering potential: A systematic review and meta-analysis of RCTs. Progress in Lipid Research. 2016;64:16\u201329. DOI: 10.1016\/j.plipres.2016.08.002","DOI":"10.1016\/j.plipres.2016.08.002"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Laitinen K, Gylling H. Dose-dependent LDL-cholesterol lowering effect by plant stanol ester consumption: clinical evidence. Lipids in Health and Disease. 2012;11(1):140. DOI: 10.1186\/1476-511X-11-140","DOI":"10.1186\/1476-511X-11-140"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Rocha VZ, Ras RT, Gagliardi AC, Mangili LC, Trautwein EA, Santos RD. Effects of phytosterols on markers of inflammation: A systematic review and meta-analysis. Atherosclerosis. 2016;248:76\u201383. DOI: 10.1016\/j.atherosclerosis.2016.01.035","DOI":"10.1016\/j.atherosclerosis.2016.01.035"},{"key":"ref38","unstructured":"Kukharchuk V.V., Susekov A.V., Zubareva M.Yu., Gorniakova N.B., Aronov D.M., Akhmedzhanov N.M. et al. Diagnosis and correction of lipid metabolism disorders for the prevention and treatment of atherosclerosis. Russian recommendations (IV revision). Cardiovascular Therapy and Prevention. 2009;8 (S3):3\u201358. [Russian: Kukharchuk V.V., Susekov A.V., Zubareva M.Yu., Gornyakova N.B., Aronov D.M., Akhmedzhanov N.M. i dr. Diagnostika i korrektsiya narushenii lipidnogo obmena s tsel'yu profilaktiki i lecheniya ateroskleroza. Rossiiskie rekomendatsii (IV peresmotr). Kardiovaskulyarnaya terapiya i profilaktika. 2009;8(S3):3-58]"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. The American Journal of Clinical Nutrition. 1999;69(1):30\u201342. DOI: 10.1093\/ajcn\/69.1.30","DOI":"10.1093\/ajcn\/69.1.30"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Kim HJ, Ahn HY, Kwak JH, Shin DY, Kwon Y-I, Oh C-G et al. The effects of chitosan oligosaccharide (GO2KA1) supplementation on glucose control in subjects with prediabetes. Food Funct. 2014;5(10):2662\u20139. DOI: 10.1039\/C4FO00469H","DOI":"10.1039\/C4FO00469H"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Mistry P. Natural cholesterol-lowering products: focus on probiotics. British Journal of Community Nursing. 2014;19(Sup11):S14\u20138. DOI: 10.12968\/bjcn.2014.19.Sup11.S14","DOI":"10.12968\/bjcn.2014.19.Sup11.S14"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Gurevich K.G., Nikityuk D.B., Nikonov E.L., Zaborova V.A., Veselova L.V., Zolnikova O.Yu. The role of probiotics and microbiota in digestion, nutrient and hormone metabolism, and hormonal background maintenance. Prevention Medicine. 2018;21 (3):45\u201350. [Russian: Gurevich K.G., Nikityuk D.B., Nikonov E.L., Zaborova E.A., Veselova L.V., Zol'nikova O.Yu. Rol' probiotikov i mikrobioty v pishchevarenii, metabolizme nutrientov, gormonov i podderzhanii gormonal'nogo fona. Profilakticheskaya meditsina. 2018;21(3):45-50]. DOI: 10.17116\/profmed201821345","DOI":"10.17116\/profmed201821345"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Kashukh E.A. Probiotics, metabolism and the functional condition of cardio-vascular system. Russian Journal of Gastroenterology Hepatology and Coloproctology. 2016;26(1):8\u201314. [Russian: Kashukh E.A., Ivashkin V.T. Probiotiki, metabolizm i funktsional'noe sostoyanie serdechno-sosudistoi sistemy. Rossiiskii zhurnal gastroenterologii, gepatologii i koloproktologii. 2016;26(1):8-14]","DOI":"10.22416\/1382-4376-2016-26-1-8-14"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Wu Y, Zhang Q, Ren Y, Ruan Z. Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials. PLOS ONE. 2017;12(6):e0178868. DOI: 10.1371\/journal.pone.0178868","DOI":"10.1371\/journal.pone.0178868"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Gordon RY, Cooperman T, Obermeyer W, Becker DJ. Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products: Buyer Beware! Archives of Internal Medicine. 2010;170(19):1722\u20137. DOI: 10.1001\/archinternmed.2010.382","DOI":"10.1001\/archinternmed.2010.382"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Zhao SP, Liu L, Cheng YC, Shishehbor MH, Liu MH, Peng DQ et al. Xuezhikang, an Extract of Cholestin, Protects Endothelial Function Through Antiinflammatory and LipidLowering Mechanisms in Patients With Coronary Heart Disease. Circulation. 2004;110(8):915\u201320. DOI: 10.1161\/01.CIR.0000139985.81163.CE","DOI":"10.1161\/01.CIR.0000139985.81163.CE"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"EFSA Panel on Dietetic Products. Scientific Opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924\/2006. EFSA Journal. 2011;9(7):2304\u201319. DOI: 10.2903\/j.efsa.2011.2304","DOI":"10.2903\/j.efsa.2011.2304"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Gliozzi M, Walker R, Muscoli S, Vitale C, Gratteri S, Carresi C et al. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. International Journal of Cardiology. 2013;170(2):140\u20135. DOI: 10.1016\/j.ijcard.2013.08.125","DOI":"10.1016\/j.ijcard.2013.08.125"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Mollace V, Scicchitano M, Paone S, Casale F, Calandruccio C, Gliozzi M et al. Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo- Controlled Study. Endocrine, Metabolic & Immune Disorders - Drug Targets. 2019;19(2):136\u201343. DOI: 10.2174\/1871530319666181203151513","DOI":"10.2174\/1871530319666181203151513"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G et al. The Role of Nutraceuticals in Statin Intolerant Patients. Journal of the American College of Cardiology. 2018;72(1):96\u2013118. DOI: 10.1016\/j.jacc.2018.04.040","DOI":"10.1016\/j.jacc.2018.04.040"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Abidi P, Zhou Y, Jiang J-D, Liu J. Extracellular Signal-Regulated Kinase\u2013Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(10):2170\u20136. DOI: 10.1161\/01.ATV.0000181761.16341.2b","DOI":"10.1161\/01.ATV.0000181761.16341.2b"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Derosa G, Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opinion on Biological Therapy. 2012;12(8):1113\u201324. DOI: 10.1517\/14712598.2012.704014","DOI":"10.1517\/14712598.2012.704014"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Onakpoya I, Spencer E, Heneghan C, Thompson M. The effect of green tea on blood pressure and lipid profile: A systematic review and meta-analysis of randomized clinical trials. Nutrition, Metabolism and Cardiovascular Diseases. 2014;24(8):823\u201336. DOI: 10.1016\/j.numecd.2014.01.016","DOI":"10.1016\/j.numecd.2014.01.016"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Tokede OA, Onabanjo TA, Yansane A, Gaziano JM, Djouss\u00e9 L. Soya products and serum lipids: a meta-analysis of randomised controlled trials. British Journal of Nutrition. 2015;114(6):831\u201343. DOI: 10.1017\/S0007114515002603","DOI":"10.1017\/S0007114515002603"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Derosa G, D\u2019Angelo A, Romano D, Maffioli P. Response to an oral fat load and effects on lipidprofile, glycemia and high-sensitivity C-reactive proteinafter soybean extract consumption. Archives of Medical Science. 2018;14(4):760\u20135. DOI: 10.5114\/aoms.2017.70993","DOI":"10.5114\/aoms.2017.70993"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Shepel\u2019skaya N.R. Phytoestrogens soybeans and their antiandrogenic actions. (Review of literature). Nutritional problem. 2010;3\u20134:26\u201331. [Russian: Shepel'skaya N.R. Fitoestrogeny soi i ikh antiandrogennoe deitsvie (obzor literatury). Problemi kharchuvannya. 2010;3-4:26-31. Dostupno na: http:\/\/www.medved.kiev.ua\/web_journals\/arhiv\/nutrition\/2010\/3-4_10\/str26.pdf]","DOI":"10.1353\/abr.2010.0018"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Baraboy V.A. Soy isoflavones: biological activity and application. Biotechnology. 2009;2(3):44\u201354. [Russian: Baraboi V. A. Izoflavony soi: biologicheskaya aktivnost' i primenenie. Biotekhnologiya. 2009;2(3):44\u201354]","DOI":"10.1016\/j.denabs.2008.08.040"},{"key":"ref58","unstructured":"Ledina A.V., Prilepskaya V.N. Phytoestrogens and soy isoflavonoids in the treatment of menopausal syndrome. Pharmateka. 2012;12(245):86\u20139. [Russian: Ledina A.V., Prilepskaya V.N. Fitoestrogeny i izoflavonoidy soi v lechenii klimaktericheskogo sindroma. Farmateka. 2012;12(245):86\u20139]"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Eslick GD, Howe PRC, Smith C, Priest R, Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. International Journal of Cardiology. 2009;136(1):4\u201316. DOI: 10.1016\/j.ijcard.2008.03.092","DOI":"10.1016\/j.ijcard.2008.03.092"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Kralova Lesna I, Suchanek P, Kovar J, Stavek P, Poledne R. Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport. Journal of Lipid Research. 2008;49(11):2414\u20138. DOI: 10.1194\/jlr.M800271-JLR200","DOI":"10.1194\/jlr.M800271-JLR200"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Preston Mason R. New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease. Current Atherosclerosis Reports. 2019;21(1):2. DOI: 10.1007\/s11883-019-0762-1","DOI":"10.1007\/s11883-019-0762-1"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"van Dijk SJ, Feskens EJ, Bos MB, Hoelen DW, Heijligenberg R, Bromhaar MG et al. A saturated fatty acid\u2013rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. The American Journal of Clinical Nutrition. 2009;90(6):1656\u201364. DOI: 10.3945\/ajcn.2009.27792","DOI":"10.3945\/ajcn.2009.27792"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews. 2015;6:CD011737. DOI: 10.1002\/14651858.CD011737","DOI":"10.1002\/14651858.CD011737"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Ketchum SB et al. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. The New England Journal of Medicine. 2019;380(1):11\u201322. DOI: 10.1056\/NEJMoa1812792","DOI":"10.1056\/NEJMoa1812792"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"ASCEND Study Collaborative Group, Bowman L, Mafham M, Wallendszus K, Stevens W, Buck G et al. Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus. The New England Journal of Medicine. 2018;379(16):1540\u201350. DOI: 10.1056\/NEJMoa1804989","DOI":"10.1056\/NEJMoa1804989"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Juonala M, Viikari JSA, Raitakari OT. Main findings from the prospective Cardiovascular Risk in Young Finns Study: Current Opinion in Lipidology. 2013;24(1):57\u201364. DOI: 10.1097\/MOL.0b013e32835a7ed4","DOI":"10.1097\/MOL.0b013e32835a7ed4"},{"key":"ref67","unstructured":"Starodubova A.V., Pavlovskaya E.V., Strokova T.V., Surkov A.G. The efficiency of diet therapy of obesity in girls. Pediatrics. Journal named after G.N. Speransky. 2014;93 (5):61\u20136. [Russian: Starodubova A.V., Pavlovskaya E.V., Strokova T.V., Surkov A.G. Effektivnost' dietoterapii ozhireniya u devushek. Pediatriya. Zhurnal im G.N. Speranskogo. 2014;93(5):61-6]"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Gooding HC, Rodday AM, Wong JB, Gillman MW, Lloyd-Jones DM, Leslie LK et al. Application of Pediatric and Adult Guidelines for Treatment of Lipid Levels Among US Adolescents Transitioning to Young Adulthood. JAMA Pediatrics. 2015;169(6):569\u201374. DOI: 10.1001\/jamapediatrics.2015.0168","DOI":"10.1001\/jamapediatrics.2015.0168"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Guardamagna O, Cagliero P, Abello F. Management of Inherited Atherogenic Dyslipidemias in Children: Children Atherogenic Dyslipidemia. Therapeutic Apheresis and Dialysis. 2013;17(2):150\u201361. DOI: 10.1111\/j.1744-9987.2012.01146.x","DOI":"10.1111\/j.1744-9987.2012.01146.x"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Hartiala O, Magnussen CG, Kajander S, Knuuti J, Ukkonen H, Saraste A et al. Adolescence Risk Factors Are Predictive of Coronary Artery Calcification at Middle Age. Journal of the American College of Cardiology. 2012;60(15):1364\u201370. DOI: 10.1016\/j.jacc.2012.05.045","DOI":"10.1016\/j.jacc.2012.05.045"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/806\/482","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:03:01Z","timestamp":1746374581000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":70,"journal-issue":{"issue":"7S","published-online":{"date-parts":[[2019,8,23]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2549","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"type":"electronic","value":"2412-5660"},{"type":"print","value":"0022-9040"}],"subject":[],"published":{"date-parts":[[2019,8,23]]}}}